Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Walczak

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Cancer Research|February 17, 2000
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytesM Leverkus, M Neumann, T Mengling, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2001
Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytesA K Simon, O Williams, J Mongkolsapaya, et al.
Oncogene|December 15, 2000
Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosisS Hinz, A Trauzold, L Boenicke, et al.
Oncogene|July 21, 2001
CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c releaseT A Röhn, B Wagenknecht, W Roth, et al.
Nature|November 20, 2015
North Pacific deglacial hypoxic events linked to abrupt ocean warmingS K Praetorius, A C Mix, M H Walczak, et al.
Behring Institute Mitteilungen|June 1, 1995
Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDSJ Dhein, H Walczak, M O Westendorp, et al.
Oncogene|August 9, 2007
Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathwayI Verbrugge, E de Vries, S W G Tait, et al.
Cell Death and Differentiation|November 4, 2006
CD4/CXCR4-mediated cell death in AIDSE Ritsou, R Breitkreutz, A Benner, et al.
Nature|June 8, 1995
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120M O Westendorp, R Frank, C Ochsenbauer, et al.
The Journal of Experimental Medicine|November 1, 1995
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damageP R Galle, W J Hofmann, H Walczak, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Cancer Research|February 17, 2000
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytesM Leverkus, M Neumann, T Mengling, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2001
Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytesA K Simon, O Williams, J Mongkolsapaya, et al.
Oncogene|December 15, 2000
Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosisS Hinz, A Trauzold, L Boenicke, et al.
Oncogene|July 21, 2001
CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c releaseT A Röhn, B Wagenknecht, W Roth, et al.
Nature|November 20, 2015
North Pacific deglacial hypoxic events linked to abrupt ocean warmingS K Praetorius, A C Mix, M H Walczak, et al.
Behring Institute Mitteilungen|June 1, 1995
Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDSJ Dhein, H Walczak, M O Westendorp, et al.
Oncogene|August 9, 2007
Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathwayI Verbrugge, E de Vries, S W G Tait, et al.
Cell Death and Differentiation|November 4, 2006
CD4/CXCR4-mediated cell death in AIDSE Ritsou, R Breitkreutz, A Benner, et al.
Nature|June 8, 1995
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120M O Westendorp, R Frank, C Ochsenbauer, et al.
The Journal of Experimental Medicine|November 1, 1995
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damageP R Galle, W J Hofmann, H Walczak, et al.
Pageof 8